Results 31 to 40 of about 2,360,733 (398)

Colorectal Liver Metastases [PDF]

Journal of Gastrointestinal Surgery, 2013
With modern multimodality therapy, patients with resected colorectal cancer (CRC) liver metastases (CLM) can experience up to 50-60 % 5-year survival. These improved outcomes have become more commonplace via achievements in multidisciplinary care, improved definition of resectability, and advances in technical skill.Even patients with synchronous and ...
Ching-Wei D, Tzeng, Thomas A, Aloia
openaire   +2 more sources

Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant

Cancer Medicine, 2019
Background Endocrine therapy is the preferred treatment for patients with hormone receptor ‐positive metastatic breast cancer (MBC). While visceral metastasis is a negative prognostic factor, few studies have distinguished between the prognoses of ...
Min He, Jun‐Jie Li, Wen‐Jia Zuo, Lei Ji, Yi‐Zhou Jiang, Xi‐Chun Hu, Zhong‐Hua Wang, Zhi‐Ming Shao   +7 more
doaj   +1 more source

Surgical treatment of colorectal cancer liver metastases

Acta Medica Lituanica, 2011
Background. Colorectal cancer is a major health problem. Approximately 25% of the patients present with liver metastases at initial diagnosis and more than 50% develop metastases in the course of illness.
Dainius ŠIMČIKAS, Marius PAŠKONIS, Vitalijus SOKOLOVAS, Eligijus POŠKUS, Kęstutis STRUPAS   +4 more
doaj   +1 more source

Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases

Gastroenterology Research and Practice, 2019
Aims. Liver metastases occur in approximately 25% of colorectal cancer (CRC) patients and cause more than 90% of deaths in CRC. Platelets play a crucial role in cancer progression and metastases.
Li Li, Xiao-Yi Huang, Na Li, Ming-ming Cui, Rui-tao Wang   +4 more
doaj   +1 more source

Radiomics of Liver Metastases: A Systematic Review

Cancers, 2020
Simple Summary Patients with liver metastases can be scheduled for different therapies (e.g., chemotherapy, surgery, radiotherapy, and ablation). The choice of the most appropriate treatment should rely on adequate understanding of tumor biology and ...
F. Fiz, L. Viganó, N. Gennaro, G. Costa, Ludovico la Bella, A. Boichuk, L. Cavinato, M. Sollini, L. Politi, A. Chiti, G. Torzilli   +10 more
semanticscholar   +1 more source

Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases

BMC Cancer, 2020
Approximately one third of all patients with CRC present with, or subsequently develop, colorectal liver metastases (CRLM). The objective of this population-based analysis was to assess the impact of resection of liver only, lung only and liver and lung ...
A. Siebenhüner, U. Güller, R. Warschkow   +2 more
semanticscholar   +1 more source

Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis

Frontiers in Oncology, 2020
Background: Organ-specific response patterns reported in previous studies indicate different response toward immune checkpoint inhibitors (ICIs) in non-small-cell lung cancer (NSCLC) patients with different metastatic sites.
Kaili Yang, Jiarui Li, Chunmei Bai, Zhao Sun, Lin Zhao   +4 more
doaj   +1 more source

Factors in perioperative care that determine blood loss in liver surgery [PDF]

, 2012
Excessive blood loss during liver surgery contributes to postoperative morbidity and mortality and the minimizing of blood loss improves outcomes. This study examines pre- and intraoperative factors contributing to blood loss and identifies areas for ...
McNally, Stephen J, McKeown, Dermot W, Parks, Rowan W; id_orcid, Garden, O. James, Parks, Rowan W., Revie, Erica J, Revie, Erica J., Garden, O James, McKeown, Dermot W., Massie, Lisa J, McNally, Stephen J., Wigmore, Stephen J, Wigmore, Stephen J., Massie, Lisa J.   +13 more
core   +1 more source

Intracranial germinoma metastasizing to the liver

Erciyes Medical Journal, 2022
[No abstract available]
Yitik, Ahmet Yasin, Sagtas, Ergin, Ufuk, Furkan   +2 more
openaire   +3 more sources

68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer

Cancer Imaging, 2019
Background The purpose of this study was to evaluate the imaging properties of hepatic metastases in 68Ga-PSMA positron emission tomography (PET) in patients with prostate cancer (PC).
Jonathan Damjanovic, Jan-Carlo Janssen, Vikas Prasad, Gerd Diederichs, Thula Walter, Winfried Brenner, Marcus R. Makowski   +6 more
doaj   +1 more source